Related references
Note: Only part of the references are listed.Factors Influencing Botulinum Toxin Dose Instability in Spasmodic Dysphonia Patients
David E. Rosow et al.
JOURNAL OF VOICE (2015)
Spasmodic Dysphonia: Onset, Course, Socioemotional Effects, and Treatment Response
Kristine Tanner et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2011)
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies
M. Zouhair Atassi et al.
IMMUNOBIOLOGY (2011)
Botulinum Toxin Treatment of Adductor Spasmodic Dysphonia: Longitudinal Functional Outcomes
Daniel Novakovic et al.
LARYNGOSCOPE (2011)
Mode of Action of Botulinum Neurotoxins: Current Vaccination Strategies and Molecular Immune Recognition
K. Roger Aoki et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2010)
Immune recognition of BoNTs A and B: How anti-toxin antibodies that bind to the heavy chain obstruct toxin action
M. Zouhair Atassi
TOXICON (2009)
Long-term botulinum toxin dose consistency for treatment of adductor spasmodic dysphonia
Paul K. Holden et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2007)
Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia
Christopher Y. Chang et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2007)
Basic immunological aspects of botulinum toxin therapy
MZ Atassi
MOVEMENT DISORDERS (2004)
Immunologic characterization of spasmodic dysphonia patients who develop resistance to botulinum toxin
JB Park et al.
JOURNAL OF VOICE (2003)
Botox treatment in adductor spasmodic dysphonia: A meta-analysis
F Boutsen et al.
JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH (2002)
Resistance to botulinum toxin injections for spasmodic dysphonia
ME Smith et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2000)
How botulinum and tetanus neurotoxins block neurotransmitter release
Y Humeau et al.
BIOCHIMIE (2000)
Share Paper
